• https://www.linkedin.com/in/fahuber/

Dr. Florian Huber, Aeon’s Chief Medical Officer, is a leading expert in musculoskeletal imaging and former Attending Radiologist and Head of Ultrasound at the University Hospital of Zurich, where he led the Zurich Ultrasound Research and Translation (ZURT) group.

Trained in Vienna, Germany, Australia, and at Massachusetts General Hospital/Harvard Medical School, he has published widely on quantitative imaging and machine-learning in radiology.

Dr. Florian Huber is Chief Medical Officer at Aeon.

Professional background

• Chief Medical Officer, Aeon (current).
• Attending Radiologist (Oberarzt), Institute for Diagnostic & Interventional Radiology, University Hospital Zurich; Clinical Principal Investigator of the Zurich Ultrasound Research & Translation (ZURT) group. 
• Belegarzt (admitting physician), Privatklinik Bethanien, Zurich (since 2025). 
• Fellow, Musculoskeletal Imaging & Intervention, Massachusetts General Hospital & Harvard Medical School (2022–2023). 
• Research focus: quantitative and multimodal musculoskeletal imaging, metabolic imaging, and opportunistic screening. 

Education

• Dr. med. univ. (MD), Medical University of Vienna (2016); study periods in Vienna, Hamburg, and Sydney; Swiss recognition (2017). 
• Board certification in Radiology (Switzerland, 2023). 
• SGUM Ultrasound proficiency certificate (2024). 

• https://de.linkedin.com/in/maja-seithe-32a49a1a0

Maja Seithe studied business and social communication at the Berlin University of the Arts and supplemented her studies with training as a certified health prevention counsellor.

As part of her studies, she published research papers on the topics of ‘Designing a preventive lifestyle for the holistic prevention of neurodegenerative diseases’ and ‘Influence of screen time on emotional development and aggression potential in children - long-term effects on behaviour in adulthood’.

Four years ago, Maja Seithe founded her own company specialising in the development and distribution of individualised, high-quality micronutrients. With her work, she aims to integrate prevention and holistic health into everyday life and make scientific findings practically accessible.

Professional Background:

• Founder and managing director of a company for individualised micronutrients
• Certified health prevention consultant

Education:

• Degree in Business and Social Communication, Berlin University of the Arts
• Training as a health and prevention consultant

Publications and Research:

• ‘How can a preventive lifestyle be designed to holistically prevent neurodegenerative diseases?’
• ‘The influence of screen time on emotional development and the potential for aggression in the first years of children's lives and the long-term consequences on behaviour in adulthood’

For Elena, clear and precise communication of medical expertise is essential. At aeon, she brings this vision to life by leading content marketing efforts, ensuring information is both accessible and impactful.

"Being informed about and actively managing your health is key to maintaining physical, cognitive, and mental well-being. In today’s age of information overload, it’s crucial to interpret and contextualize findings from studies and other sources correctly, while critically assessing the interests behind them. I ensure that all the content we produce is based on reliable sources."

• https://www.linkedin.com/in/elena-busarac/

Elena completed her studies in Business Administration and Biology at the University of Zurich. During her studies, she gained valuable experience as a Marketing Manager at a housing development company and in the startup environment. She then led a research project on iron deficiency and authored a book titled "The Iron Solution," which ranked as the number 1 medical research e-book on Kindle in Germany and the USA. In 2023, she began working as the first marketing employee at Aeon.

Education:

• Biology & Business Administration, University of Zurich (2018–2022, magna cum laude)
• Student in Economics, ETH Zurich (2018–2020)